Parathyroid hormone (1-34) counteracts the suppression of interleukin-11 expression by glucocorticoid in murine osteoblasts: a possible mechanism for stimulating osteoblast differentiation against glucocorticoid excess

Endocrinology. 2013 Mar;154(3):1156-67. doi: 10.1210/en.2013-1915. Epub 2013 Feb 8.

Abstract

Glucocorticoid (GC) excess causes a rapid loss of bone with a reduction in bone formation. Intermittent PTH (1-34) administration stimulates bone formation and counteracts the inhibition of bone formation by GC excess. We have previously demonstrated that mechanical strain enhances interleukin (IL)-11 gene transcription by a rapid induction of ΔFosB expression and protein kinase C (PKC)-δ-mediated phosphorylation of phosphorylated mothers against decapentaplegic (Smad)-1. Because IL-11 suppresses the expression of dickkopf-1 and -2 and stimulates Wnt signaling, IL-11 appears to mediate at least a part of the effect of mechanical strain on osteoblast differentiation and bone formation. The present study was undertaken to examine the effect of PTH(1-34) and GCs on IL-11 expression in murine primary osteoblasts (mPOBs). PTH(1-34) treatment of mPOBs enhanced IL-11 expression in a time- and dose-dependent manner. PTH(1-34) also stimulated ΔFosB expression and Smad1 phosphorylation, which cooperatively stimulated IL-11 gene transcription. PTH(1-34)-induced Smad1 phosphorylation was mediated via PKCδ and was abrogated in mPOBs from PKCδ knockout mice. Dexamethasone suppressed IL-11 gene transcription enhanced by PTH(1-34) without affecting ΔFosB expression or Smad1 phosphorylation, and dexamethasone-GC receptor complex was bound to JunD, which forms heterodimers with ΔFosB. High doses of PTH(1-34) counteracted the effect of dexamethasone on apoptosis of mPOBs, which was blunted by neutralizing anti-IL-11 antibody or IL-11 small interfering RNA. These results demonstrate that PTH(1-34) and GCs interact to regulate IL-11 expression in parallel with osteoblast differentiation and apoptosis and suggest that PTH(1-34) and dexamethasone may regulate osteoblast differentiation and apoptosis via their effect on IL-11 expression.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alkaline Phosphatase / genetics
  • Animals
  • Apoptosis / drug effects
  • Cell Differentiation / drug effects
  • Cells, Cultured
  • Dexamethasone / pharmacology
  • Gene Expression Regulation / drug effects
  • Interleukin-11 / genetics*
  • Mice
  • Osteoblasts / cytology
  • Osteoblasts / drug effects*
  • Osteoblasts / metabolism*
  • Osteocalcin / genetics
  • Osteoprotegerin / genetics
  • Parathyroid Hormone / pharmacology*
  • Phosphorylation / drug effects
  • Promoter Regions, Genetic
  • Protein Kinase C-delta / metabolism
  • Proto-Oncogene Proteins c-fos / genetics
  • Proto-Oncogene Proteins c-fos / metabolism
  • Proto-Oncogene Proteins c-jun / metabolism
  • RANK Ligand / genetics
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • RNA, Small Interfering / genetics
  • Receptors, Glucocorticoid / metabolism
  • Signal Transduction / drug effects
  • Smad1 Protein / metabolism

Substances

  • Fosb protein, mouse
  • Interleukin-11
  • Osteoprotegerin
  • Parathyroid Hormone
  • Proto-Oncogene Proteins c-fos
  • Proto-Oncogene Proteins c-jun
  • RANK Ligand
  • RNA, Messenger
  • RNA, Small Interfering
  • Receptors, Glucocorticoid
  • Smad1 Protein
  • Smad1 protein, mouse
  • Tnfrsf11b protein, mouse
  • Tnfsf11 protein, mouse
  • junD protein, mouse
  • Osteocalcin
  • Dexamethasone
  • Protein Kinase C-delta
  • Alkaline Phosphatase